Physician profile
Armen Derian
NPI 1275978876
$7,405.06
in general payments reported to CMS, 2019-2025
33 companies · $768 in 2025
The $768 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,908 · 2020: $848 · 2021: $1,854 · 2022: $270 · 2023: $165 · 2024: $591 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502 · Education: $22.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.43 |
| Education | $22.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,075.67 | 2021-2025 | Octrode, Proclaim, Eterna |
| Arthrex, INC. | $1,907.00 | 2019 | |
| Impactortho, INC. | $580.12 | 2020 | |
| Goode Surgical INC | $452.53 | 2019 | |
| Stimwave Technologies Incorporated | $272.04 | 2019 | |
| Medtronic, INC. | $256.62 | 2022-2024 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $251.11 | 2024-2025 | Prospera |
| Globus Medical, INC. | $238.98 | 2025 | Excelsius Gps, Sable, Senza |
| Nevro Corp. | $171.03 | 2020-2024 | Senza |
| Spinesmith Holdings, LLC | $123.55 | 2019 | |
| Almatica Pharma LLC | $104.75 | 2021-2022 | |
| Saluda Medical Americas, INC. | $96.80 | 2024 | Evoke |
| Spr Therapeutics, INC | $90.79 | 2023 | Sprint Pns System |
| Nuvasive, INC. | $87.17 | 2020 | |
| Hydrocision, INC. | $73.85 | 2024 | Tenjet |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $61.47 | 2022 | |
| Medtronic USA, INC. | $55.76 | 2019 | |
| Amgen INC. | $52.48 | 2020-2021 | |
| Ziehm-Orthoscan, INC. | $48.06 | 2019 | |
| Nalu Medical, INC. | $44.37 | 2025 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $44.10 | 2023 | Roxybond |
| Boston Scientific Corporation | $37.50 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Bioventus LLC | $36.79 | 2019-2020 | |
| Vertos Medical, INC. | $35.72 | 2024 | Mild Device Kit |
| Abbvie INC. | $34.21 | 2024 | |
| Trice Medical, INC. | $30.87 | 2022 | |
| Depuy Synthes Sales INC. | $29.84 | 2022-2023 | Orthovisc, Monovisc |
| Otto Bock Healthcare LP | $22.38 | 2024 | |
| Orthogenrx INC. | $20.49 | 2021 | |
| Mml US, INC. | $18.70 | 2025 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $17.78 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.94 | 2022 | |
| Stratus Medical, LLC | $15.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armen Derian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.